Press "Enter" to skip to content

Linden Capital Partners Acquires RQM+

A Chicago-based private equity firm, Linden Capital Partners, has bought a majority stake in RQM+, a PA-based firm specializing in compliance, compliance quality, and regulatory consulting for medical device and in-vitro diagnostics producers.

According to a release from the firm, the deal will witness Chartwell Investments Entrepreneur & Founder Capital and DFW Capital Partners make an exit from the company. A couple of PE companies made an investment in October 2019 in predecessor consulting firm R&Q and then collaborated with merged it with UK-based Maetrics in September 2020 in order to make the biggest medical device-focused worldwide quality and regulatory consultancy.

RQM+ has more than 400 employees across offices in Europe and the US and functions widely fragmented and unpenetrated portion of the consulting market. The company’s new private equity owners will look to persist in scaling the company in order to monetize on increasing demand for services as the EU transforms to a more stringent dictatorial framework for medical devices.Incoming board member of RQM+, Richard Thomas, said that they order Lisa Casavant, Maria Fagan and the entire management team at RQM+ to develop an astonishing business that offers enhanced services and quality needed to help their clients locate dynamic and increasingly complicated regulatory landscape.

Incoming board member of RQM+ & partner at Linden, Michael Farah, said that the company’s environment is a straight result of the company’s longstanding and dedicated outsourced medical device services segment attempt and they are happy to collaborate with a firm that has such a strong position in the market at present. He also added that they are eagerly looking forward to supporting the complete RQM+ team as they look up to grow both through acquisitions and organically as well.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *